ArticlePloS one2017
Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy.
Deborah Charych et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
83 papers cite itlatest 60 shown
this papertrialcites it